Artificial Intelligence for Infectious Disease Detection: Prospects and Challenges

The emergence of Artificial Intelligence (AI) as a transformative force in healthcare has sparked a growing interest in its application to infectious disease detection. The study provides an insightful overview of the promising prospects and intricate challenges associated with harnessing AI’s capabilities for the early identification and effective management of infectious diseases. Infectious diseases remain a pressing global concern, often necessitating rapid and accurate detection to mitigate their impact. The integration of AI offers a paradigm shift in disease surveillance, enabling the real-time analysis of diverse data streams encompassing clinical records, genomic sequences, social media trends, and environmental factors. Through intricate pattern recognition and predictive modeling, AI holds the potential to expedite outbreak identification, trace transmission pathways, and forecast disease dynamics, facilitating proactive public health interventions. Nevertheless, the voyage towards seamless AI-driven infectious disease detection is accompanied by multifaceted challenges. Data heterogeneity, availability, and quality emerge as foundational obstacles, demanding comprehensive strategies for data aggregation, curation, and sharing. Furthermore, the deployment of AI models mandates a balance between complexity and interpretability, necessitating the development of algorithms that not only excel in performance but also afford clear insights into decision-making processes. Ethical dimensions also loom large in this landscape, with privacy concerns and algorithmic biases necessitating careful consideration. The quest for equitable AI-driven detection mandates the navigation of ethical frameworks that prioritize patient confidentiality, informed consent, and the mitigation of algorithmic biases that may disproportionately impact marginalized populations.